Bing Xiu

504 total citations
25 papers, 358 citations indexed

About

Bing Xiu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Bing Xiu has authored 25 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Bing Xiu's work include Lymphoma Diagnosis and Treatment (12 papers), CAR-T cell therapy research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Bing Xiu is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), CAR-T cell therapy research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Bing Xiu collaborates with scholars based in China, United States and Israel. Bing Xiu's co-authors include Aibin Liang, Wenjun Zhang, Steven C. Ziesmer, Deanna M. Grote, Stephen M. Ansell, Anne J. Novak, Anmei Deng, Huazong Zeng, Yi-Qing Qu and Zhi Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Bing Xiu

21 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Xiu China 9 190 138 128 117 71 25 358
Hannelore Madle Germany 5 142 0.7× 159 1.2× 173 1.4× 88 0.8× 82 1.2× 6 347
Jennifer Kimberly Lue United States 11 146 0.8× 244 1.8× 170 1.3× 94 0.8× 19 0.3× 40 435
Annette Wolf Germany 7 159 0.8× 222 1.6× 179 1.4× 151 1.3× 152 2.1× 9 455
Lorena Barclay Canada 5 200 1.1× 137 1.0× 169 1.3× 95 0.8× 75 1.1× 7 376
Kelly Foster United States 8 180 0.9× 285 2.1× 63 0.5× 68 0.6× 31 0.4× 10 444
Victoria L. Peek United States 6 157 0.8× 126 0.9× 39 0.3× 71 0.6× 45 0.6× 20 312
Elisa Mandato Italy 8 165 0.9× 176 1.3× 136 1.1× 108 0.9× 36 0.5× 13 390
M. Nieves Calvo-Vidal United States 7 148 0.8× 143 1.0× 96 0.8× 24 0.2× 70 1.0× 7 290
Ying-Wei Lin United States 9 202 1.1× 340 2.5× 236 1.8× 111 0.9× 74 1.0× 9 557
Jens Wuerthner United States 11 245 1.3× 108 0.8× 124 1.0× 52 0.4× 31 0.4× 24 335

Countries citing papers authored by Bing Xiu

Since Specialization
Citations

This map shows the geographic impact of Bing Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xiu more than expected).

Fields of papers citing papers by Bing Xiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xiu. The network helps show where Bing Xiu may publish in the future.

Co-authorship network of co-authors of Bing Xiu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xiu. A scholar is included among the top collaborators of Bing Xiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xiu. Bing Xiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xue, Bing Xiu, Muye Yang, et al.. (2025). Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers. Journal of Biological Chemistry. 301(9). 110515–110515. 1 indexed citations
2.
Liu, Yifan, Lili Zhou, Yan Lu, et al.. (2024). CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations. Cytotherapy. 26(12). 1465–1471. 3 indexed citations
3.
Liu, Yifan, Yang Liu, Sanfang Tu, et al.. (2024). CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma. Current Research in Translational Medicine. 73(1). 103477–103477. 2 indexed citations
4.
Zhang, Suxia, Xuyou Zhu, Tingting Zhang, et al.. (2024). Clinical and cytological characteristics of serous effusions in 69 cases of lymphoma patients. Diagnostic Cytopathology. 52(11). 649–661.
5.
Zhu, Jingjing, Xinyu Zhu, Yan Dong, et al.. (2023). Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors. Pathology & Oncology Research. 29. 1611070–1611070.
6.
7.
Pan, Mengmeng, Pingping Yang, Bing Li, et al.. (2021). Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma. Frontiers in Genetics. 12. 648800–648800. 5 indexed citations
8.
9.
10.
Xu, Yangyang, Zhenchuan Liu, Ping Li, et al.. (2020). MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research. 39(1). 238–238. 18 indexed citations
11.
Lu, Jinyuan, You Wu, Bing Li, et al.. (2020). Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma. Oncology Letters. 20(4). 47–47. 5 indexed citations
12.
Xiu, Bing, Hao Wu, Bing Li, et al.. (2017). Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study. Experimental and Therapeutic Medicine. 15(2). 1966–1974. 4 indexed citations
13.
Xia, Fang, Bing Xiu, Zhi-Zhang Yang, et al.. (2017). The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma. Medicine. 96(15). e6398–e6398. 44 indexed citations
14.
Wang, Lei, Wenjun Zhang, Yi Ding, et al.. (2015). Up-regulation of VEGF and its receptor in refractory leukemia cells.. PubMed. 8(5). 5282–90. 17 indexed citations
15.
Jones, Jason M., Steven C. Ziesmer, Deanna M. Grote, et al.. (2014). Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma. Clinical Cancer Research. 20(11). 2862–2872. 81 indexed citations
16.
17.
Yang, Zhi‐Zhang, Deanna M. Grote, Steven C. Ziesmer, et al.. (2013). Soluble and Membrane-Bound TGF-β-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma. PLoS ONE. 8(3). e59456–e59456. 58 indexed citations
18.
Wang, Lei, Wenjun Zhang, Bing Xiu, et al.. (2013). Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells. International Journal of Biological Macromolecules. 63. 49–55. 10 indexed citations
19.
Liang, Wei, et al.. (2012). Down-regulation of SENP1 Expression Increases Apoptosis of Burkitt Lymphoma Cells. Asian Pacific Journal of Cancer Prevention. 13(5). 2045–2049. 14 indexed citations
20.
Liang, Aibin, et al.. (2012). N-Propionyl polysialic acid precursor enhances the susceptibility of multiple myeloma to antitumor effect of anti-NprPSA monoclonal antibody. Acta Pharmacologica Sinica. 33(12). 1557–1562. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannelore Madle Breakdown of academic impact, for papers by Jennifer Kimberly Lue Breakdown of academic impact, for papers by Annette Wolf Breakdown of academic impact, for papers by Lorena Barclay Breakdown of academic impact, for papers by Kelly Foster Breakdown of academic impact, for papers by Victoria L. Peek Breakdown of academic impact, for papers by Elisa Mandato Breakdown of academic impact, for papers by M. Nieves Calvo-Vidal Breakdown of academic impact, for papers by Ying-Wei Lin Breakdown of academic impact, for papers by Jens Wuerthner
Rankless by CCL
2026